UK News Archive

The UK News Archive contains resources intended for journalists only.

2021

September

Media Release / Sep 01, 2021

World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio® ▼(inclisiran)

Read More

August

Media Release / Aug 19, 2021

Novartis’ Rydapt ®▼ (midostaurin) is the first and only treatment to receive NICE recommendation for routine funding for patients in England and Wales living with advanced systemic mastocytosis (AdvSM)

Read More

July

Media Release / Jul 13, 2021

Novartis BIOME UK announces selection for the HealthHub 21 Challenge, in collaboration with KQ Labs and LifeArc

Read More
Media Release / Jul 12, 2021

The Scottish Medicines Consortium recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)

Read More

June

Media Release / Jun 17, 2021

Novartis Cosentyx® (secukinumab) recommended by NICE for adults with non-radiographic axial spondyloarthritis (nr-axSpA)

Read More
Media Release / Jun 04, 2021

Novartis continues to push the boundaries of innovation, reimagining medicine, with bold science as it today unveils strong presence at ASCO, including overall survival data in prostate and breast cancer

Read More

April

Media Release / Apr 21, 2021

NICE recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)

Read More
Media Release / Apr 21, 2021

Industry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care

Read More
Media Release / Apr 07, 2021

Novartis receives European and UK licence for Kesimpta® ▼ (ofatumumab), the first self-administered B-cell therapy for patients with relapsing forms of MS

Read More
Media Release / Apr 06, 2021

Novartis UK updated statement on Estradot Stock

Read More

Related Links